Sonnie Kim Ashchi MD FACOG Patient No 1 Emily is 14 years old started her first menses last year irregular at the beginning now regular monthly But she reports heavy bleeding that soaks through her uniform And very inconvenient to have heavy bleeding during her soccer lacro ID: 622882
Download Presentation The PPT/PDF document "Management of Abnormal Uterine Bleeding" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Management of Abnormal Uterine Bleeding
Sonnie
Kim-
Ashchi
, MD. FACOGSlide2
Patient No 1
Emily is 14 years old, started her first menses last year, irregular at the beginning , now regular monthly. But she reports heavy bleeding that soaks through her uniform. And very “ inconvenient” to have heavy bleeding during her soccer/ lacrosse/crew practices
.Slide3
Patient No2.
Laura is 26 years old
trying to get pregnant for last 2 years. She has 4 to 5 periods a year. She is getting more hair in her face and darker in back of her neck.
She is getting nervous about her future fertility. Slide4
Patient No. 3
Mrs. Robinson is 50 years old. Her last period was 6 months ago. Now bleeding heavily for 10 days passing clots. Slide5
Patient No. 4
Mrs. Hopkins is 70 years old. She has been postmenopausal since her early 50’s. She noticed pink spotting about three months ago. At that time, she was too embarrassed to her PCP during her routine checkup. But now, spotting changed to heavy bright red bleeding. Slide6
Abnormal Uterine Bleeding Associated with Ovulatory Dysfunction ( AUB-O)
The most common cause for
gyn
visits and referrals.Ovulatory dysfunction presents with heavy irregular uterine bleeding due to the effects of chronic unopposed estrogen on the endometrium.
Acute AUBChronic AUB- topic todaySlide7
Causes of Anovulation
Physiologic
Pathologic
Adolescence
PregnancyLactationPerimenopause
Hypothalamic dysfunction (secondary to anorexia nervosa)Hyperprolactinemia
Primary pituitary diseasePremature ovarian failureThyroid diseaseHyper androgenic anovulation(PCOS, CAH, or Androgen-producing tumor)Iatrogenic(secondary to radiation or chemotherapy)
MedicationSlide8
Causes of AUB by FIGO and ACOG
PALM
-Structural Causes
COEIN-Nonstructural causes
P
olyp and PregnancyA
denomyosisLeiomyomaMalignancy and
hyperplasia
C
oagulopathy
O
vulatory dysfunction
E
ndometrial
I
atrogenic
N
ot yet classified
International Federation of Gynecology and Obstetrics ( FIGO)
American College of Ob/
Gyn
( ACOG)Slide9
Age-Based Consideration in Differential Diagnosis
13-18
Years
Differential diagnosis is similar to other age groups except endometrial hyperplasia and malignancy.
1. Anovulation; Hypothalamic immaturity ( 90%) 2.Stree-exercise-induced 3. Obesity 4. Coagulation disorder like Von Willebrand disease
5. Pregnancy, sexual trauma, STD regardless of her “reported “ sexual history
6. Look for PCOS such as acne, hirsutism, Slide10
Age-Based Consideration in Differential Diagnosis;
19-39
YearsPCOS is one of the most common causes in this group.
AnovulationObesity is comorbid condition.Endocrine disorder eg. hypothyroidism
PregnancyPolyp, fibroids, adenomyosisMedication related esp. OCPInfection
Premalignant or malignant endometrial pathology must be considered for high risk patients especially medical management is not successful.Slide11
Age-Based Considerations in differential diagnosis ;
40 Years to Menopause
Most likely normal perimenopausal changes with irregular sometimes heavy menses
Anovulation-
unppopsed estrogen and hyperplasiaMean age of menopause is 52 years.The average duration of the menopausal transition is 4 years.
Polyp, fibroid, adenomyosisHyperplasia or cancerPregnancy must be excluded.Definition of
Menopause-cessation of menses for 12 consecutive months, NOT blood hormone testsSlide12
Age-Based Considerations in
differential diagnosis;
Menopause and on
1.Vaginal atrophy
2.Cancer/polyp3. Estrogen therapySlide13
Basic information about your patients via,,,,
History
Physical Exam
Pertinent medical and surgical history-- Surgery-related bleeding? Bleeding after dental work? Bruising easily? Frequent nose bleeding or gum bleeding? Family history of bleeding?
Medication– anticoagulant? Chemo agents?
Detailed gyn history-menarche? Current bleeding frequency, interval, duration, related symptoms such as vaginal discharge, pain, LMP
General—signs of systemic illness, ecchymosis, thyromegaly, signs of
hyperandrogenism
such as hirsutism, acne, male pattern balding. Acanthosis
nigricans
Pelvic exam including speculum exam and bimanual exam to look for genital trauma, cervical tumor, uterine enlargement. Slide14
Based on patient’s history and physical examination,,,,
Laboratory Testing
Imaging
Urine pregnancy test
Complete Blood Counts and platelets
TSHIf indicated, von Willebrand-ristocetin cofactor activity, vW factor antigen and Factor VIII, Liver Function Test.Pap smearEndometrial biopsy if older than 45 years or “ high risk” patients
Transvaginal or transabdominal ultrasoundSonohysterogram
HysteroscopySlide15
Treatment approach to guide therapy for AUB-O
The choice of treatment is according to the goals of therapy
√ Age group, 13 ? 25? 50? 75?
√ To stop acute bleeding? √ To avoid future irregular heavy bleeding? √ Need for contraception?
√ Need for comorbidity such as anemia √ Need for surgical treatment? Only when medical therapy fails, is contraindicated, is not tolerated by the patient, or the patient has intracavitary lesions.Slide16
FIGO and ACOG recommends
Abnormal Uterine Bleeding, NOT Dysfunctional Uterine bleeding, DUB which was used in the past for the bleeding with no systemic or structural cause.
DUBSlide17
Treatment
for AUB-O
Progestin Therapy
Medroxyprogesterone
acetate( Provera)
Megestrol acetate (Megace) Norethindrone
acetate(Aygestin)Depo Medroxyprogesterone
acetate (
Depo
Provera)
Implanon
/
Nexaplanon
Levonorgestrel
-releasing intrauterine device (
Mirena
or Skyla or
Liletta
)Slide18
Treatment for
AUB-O
Progesterone and Estrogen combination therapy
Oral contraceptives (Monophasic vs.
Triphasic vs. combination extended cycle)Transdermal patchesVaginal ringsSlide19
Surgical Management of AUB-O,
ONLY IF
medical managements fail
Hysteroscopy Dilatation and Curettage
Endometrial ablationHysterectomySlide20
Patient No 1
Emily is 14 years old, started her first menses last year, irregular at the beginning , now regular monthly. But she reports heavy bleeding that soaks through her uniform. And very “ inconvenient” to have heavy bleeding during her soccer/ lacrosse/swimming practices.
Lab tests- urine
hCG
, CBC, TSH,
vWd factorTreatment – Iron supplements and/or Low dose OCP or Progesterone IUD ( Skyla)Consider CONTINOUS combined hormonal contraceptives e.g., Seasonale
, Seasonique. 4 periods a yearSlide21
Patient No2.
Laura is 34 years old Gravida 0, having noncyclic menses, 4 to 5 periods a year. She is not sure about her fertility.
Any hyper androgenic signs?
Obesity?
Labs-CBC, TSH, Fasting ProlactinPelvic ultrasound
Endometrial biopsy for high risk patients for hyperplasia or even cancerFertility desired? If yes, induce ovulation. If not, OCP or Levonorgestrel IUD (Mirena or Liletta
) whose benefit includes reduction of endometrial cancer.Weight Loss and Exercise Slide22
Patient No. 3
Need to rule out endometrial hyperplasia and cancer with EMB!
Labs- B HCG, CBC, TSH, Prolactin
Pelvic ultrasound
Treatment- low dose OCP, cyclic progestin therapy, Mirena IUD or endometrial ablation.Remember perimenopausal women can get pregnant!!
Mrs. Robinson is 50 years old, last period was 6 months ago. Now bleeding heavily for 10 days passing clots. Very frustrated.Slide23
Patient No. 4
Mrs. Hopkins is 70 years old. She has been postmenopausal since her early 50’s. She noticed pink spotting about three months ago. At that time, she was embarrassed to see her gynecologist. But now spotting changed to heavy bright red bleeding.
EMDOMETRIAL BIOPSY!!
Transvaginal
ultrasound especially endometrial stripeSlide24
When is EMB indicated?
§ Purpose of EMB is to rule out hyperplasia and cancer.
§ Incidences of endometrial cancer in different age groups
Younger than 20; 0.2 in 100, 000 Age 20-34; 1.6%
Age 35-44; 6.2%, the incidence increases with aging, Age 70-74; 88 cases per 100,ooo§ EMB is indicated for patients older than 45 years with AUB-O
§ Also indicated younger than 45, 1.if medical management failed and systemic diseases such as leukemia or liver disease were ruled out in young patients.
2.patients with h/o unopposed estrogen exposure such as obesity (BMI greater than 30) and PCOS, chronic anovulation, h/o breast cancer,
Tamoxifen
use, family h/o endometrial cancer. Slide25
Surgical management for AUB-O
ONLY IF
medical managements fail
Saline infused
sonohysterogramHysteroscopyDilation and CurettageEndometrial ablation
HysterectomySlide26
Surgical management for AUB-O
Hysteroscopy and Dilation and Curettage
Saline infusion
sonohysteroscopySlide27
Surgical management for AUB
Endometrial ablation
“
Hysterectomy Alternative
”Can be done in the office,= Just copay for the office visit
Resectoscopic endometrial ablation since 1937Global nonresectoscopic ablation
Freeze-Cryotherapy Radiofrequency electricity-Novasure
Heated fluid-
Thermachoice
,
HydroThermAblator
Microwave-
Microsulis
Treatment Goal is to “ normalize “ menses ( 70 to 90 % patient satisfaction rate) ,
NOT
amenorrhea.
Prerequisites -uterus less than 10 cm, no
cavitary
lesion, adequate contraception after the procedure
Patient must be counseled about the risks
of masking
endometrial
cancer in the future.
Post ablation
Asherman
syndrome,
synechiae
, endometrial distortion/strictureSlide28
Surgical management for AUB
Endometrial Ablation
Therma
Choice
Hydro
ThermAblator
)
Novasure
MicroSulis
Resectoscopic
ablationSlide29
Surgical management for AUB; Hysterectomy
ONLY
indicated for medical management failure or patient’s desire for definitive treatment.Slide30
daVinci robot assisted total hysterectomy
Advantages for the patients
*Minimally invasive.
*Less painful.
*less blood loss, about 50 cc.
*Less infection.
*Less hospitalization days.*More cosmetically appealing.
*Quicker recovery.
*Faster return to normal life/work.
Advantages for the surgeons
*Much improved 3 D visualization
*Less complication
*Less ergonomically challenging,, Less tiring
Single Site EntrySlide31
Last Note,,Health
apps for Patients
Objective data collection instead of “ I bleed a lot”Slide32
Thank you
Questions about Abnormal Uterine Bleeding?